Aster Dm Healthcare Ltd. · NSE:ASTERDM
Aster Dm Healthcare — Q3 FY2019 Earnings Presentation
41 slides from Aster Dm Healthcare's earnings presentation, Feb 13, 2019
Slide 1: Stock exchange cover letter for investor presentation
SEC/ADM HL/SE/2018/138 13 February 2019 The Secretary The Manager, Listing Department, Listing Department, BSE Limited, The National Stock Exchange of India Ltd 1'1 Floor, Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G Dalal Street, Mumbai 400001 Sandra Kurla Complex Scrip Code: 540975 Sandr
Slide 2: Investor Presentation – Quarter & nine months ended 31st Dec-2018
ASTER OM HEALTHCARE Investor Presentation – For the quarter & nine months ended 31st Dec-2018 www.asterdmhealthcare.com1
Slide 3: Disclaimer
I I Disclaimer This presentation has been prepared by Aster DM Healthcare Limited (the "Company"), content of which was compiled from sources believed to be reliable for informational purposes only and are based on information regarding the Company and the economic, regulatory, market and other co
Slide 4: Aster – Snapshot, Evolution and Footprint
I I Aster – Snapshot, Evolution and Footprint Aster – An Integrated Healthcare Provider Operational and Financial Overview Strategy and Leadership 3
Slide 5: Geographical Footprint
I I Geographical Footprint Hospitals – 10 GCC Clinics – 105 Pharmacies - 219 Hospitals - 11 Clinics - 8 INDIA United Arab Emirates Kerala Medcare Hospital, Dubai • Aster Medcity, Kochi • • Aster MIMS, Calicut • Medcare Orthopaedics and Spine Hospital, Dubai • Aster MIMS, Kottakkal • Aster Hospital M
Slide 6: Aster DM Healthcare – At a Glance (1/2)
I I Aster DM Healthcare – At a Glance (1/2) HOSPITALS One of Largest Private CAPACITY BEDS healthcare service providers GCC: 1,052 GCC: 10 5,090 21 India: 4,038 India: 11 operating in Asia (GCC & India) PATIENT VISITS – FY19 9M Present in 9 Countries CLINICS (UAE, Saudi Arabia, Qatar, Oman, ~13.4 mn
Slide 7: Aster DM Healthcare – At a Glance (2/2)
I I Aster DM Healthcare – At a Glance (2/2) Revenue - FY19 9M Revenue - FY19 9M India 17% Pharmacies GCC <- INR ~5,762 Cr ._____> 26% Clinics Hospitals 49% 25% 83% EBITDA - FY19 9M EBITDA - FY19 9M India Pharmacies 16% 19% <- INR ~513 Cr ._____> Clinics 29% Hospitals 52% GCC 84% Note: 1. Revenue and
Slide 8: The Aster DM Healthcare Edge
I I The Aster DM Healthcare Edge Aster DM – A Healthcare Ecosystem • Presence across hospitals, clinics & pharmacies and providing primary, secondary and tertiary/ quaternary care • Strategic and sizeable network of clinics enable patient feeder Differentiated Asset-light Business Model in GCC struc
Slide 9: Aster DM Healthcare - Evolution
I I Aster DM Healthcare - Evolution Building the foundations New geographies, segments Brand “Aster” was formed, private equity Robust Growth across all segments and and service offerings investment, further expansion geographies; Rapid Expansion in India 1987: Commenced 2003: Expansion to new geogr
Slide 10: Robust Growth Over Last Years
I I ROBUST GROWTH OVER LAST 5 YEARS Outpatient Count (in mn) Inpatient Count (in '000) Aster DM - Revenue from Operations (INR Cr) 6,721 7.8 6.3 211 5,931 5,762 6.7 163 5,250 5.6 158 125 3,876 ■ Ill 4.2 2,871 ■ II 3.4 104 85 1,922 5,762 2.2 6.3 4,937 • 5.7 38 151 163 - - - - - - - - - - - - - - - FY
Slide 11: Aster – An Integrated Healthcare Provider
I I Aster – Snapshot, Evolution and Footprint Aster – An Integrated Healthcare Provider Operational and Financial Overview Strategy and Leadership 10
Slide 12: Aster - An Integrated Healthcare Provider
I I Aster - An Integrated Healthcare Provider FY18 Operational Information 1,700+ 2,10,000+ Cardiovascular IP Discharges Surgeries ~4.9 mn Clinic OPD Visits -- 9,500+ General Surgeries 550+ Bariatric Surgeries ₹ 900+ Joint 1,200+ ~ 9.2 mn Replacements Spine Surgeries Pharmacy Visits 7,000+ 200+ Urol
Slide 13: Aster – A Healthcare Ecosystem
I I Aster – A Healthcare Ecosystem PATIENT LIFE CYCLE MANAGEMANT RESOURCE TALENT MANAGEMENT Aster, over 30 years, has created a ·,............... healthcare eco-system across two .-.... .::.- ··•....... _ ·•.....• ..~..: -- geographical regions .. .!111!111!11'1•' In GCC region, Aster’s primary
Slide 14: GCC Healthcare – Unique Traits
I I GCC Healthcare – Unique Traits Population (mn) I Healthcare market in GCC states have developed certain unique traits due to the higher expat and working age population I Expat% -> II ~80% I I~~70% ~45% ~30% Prevalence of Primary and Secondary Healthcare Facilities (Private Sector) 32.0 Due to
Slide 15: Aster - Awards & Service Excellence
I I Aster - Awards & Service Excellence JCI Accreditation for 6 Hospitals Padma Shri Award 1 Clinic and 1 diagnostic centre “The Sheikh Khalifa Excellence Award” Medcare Hospital Dubai, Medcare Dr. Azad Moopen, Chairman & (2018) Orthopaedics and Spine Hospitals, Aster Managing Director – Aster DM Ma
Slide 16: Operational and Financial Overview
I I Aster – Snapshot, Evolution and Footprint Aster – An Integrated Healthcare Provider Operational and Financial Overview Strategy and Leadership 15
Slide 17: Key Highlights – FY19 Q3 (Clinical)
I I Key Highlights – FY19 Q3 Clinical Highlights Aster CMI Hospital: Ace Split Liver Transplant was performed on a 32 month old baby Citizen of Iraq weighing 212kg and with a BMI of 90 underwent revision Sleeve and MGB at Aster CMI hospital; the patient was previously operated in Germany Aster
Slide 18: Key Highlights – FY19 Q3 (Operational)
I I Key Highlights – FY19 Q3 Operational Highlights Aster CMI was declared as “Center of Excellence for Bariatric & Metabolic surgery” by the “Obesity & Metabolic Surgery Society of India” Aster Medcity has launched a separate dedicated area for Physical Medicine and Rehabilitation consisting of
Slide 19: Revenue and Profitability Snapshot - FY19 Q3
I I Revenue and Profitability Snapshot - FY19 Q3 Revenue from Operations EBITDA (excl. Other Income) Adjusted PAT3 _J ₹ 1814 _J ₹ 2150 _J₹ 172 _J ₹ 263 _J ₹ 71 _J ₹ 100 12.2% 4.7% 9.5% 3.9% FY18 Q3 FY19 Q3 FY18 Q3 FY19 Q3 FY18 Q3 FY19 Q3 Constant currency growth of Revenue, EBITDA and PAT is ~9%,
Slide 20: Revenue and Profitability Snapshot - FY19 9M
I I Revenue and Profitability Snapshot - FY19 9M Revenue From Operations EBITDA (excl. Other Income) Adjusted PAT3 _J₹ 4937 _J₹ 5762 _J₹ 350 _J₹ 513 _J₹ -6 ₹ 125 _ y 8.9% 2.2% 7.1% -0.1% FY18 9M FY19 9M FY18 9M FY19 9M FY18 9M FY19 9M Constant currency growth of Revenue and EBITDA is ~10% and ~38%
Slide 21: Business – Snapshot (1/2)
I I Business – Snapshot (1/2) GCC INDIA CONSOLIDATED FY18 Q3 FY19 Q3 FY18 Q3 FY19 Q3 FY18 Q3 FY19 Q3 • Total Capacity Beds 867 1,052 3,887 4,038 4,754 5,090 • Operational Beds 752 872 2,759 2,928 3,511 3,800 • ALOS (Days) 1.9 2.0 3.7 3.6 3.0 3.0 • Occupancy 55% 59% 64% 63% 62% 62% • Outpatient Visit
Slide 22: Business – Snapshot (2/2)
I I Business – Snapshot (2/2) GCC INDIA CONSOLIDATED FY18 Q3 FY19 Q3 FY18 Q3 FY19 Q3 FY18 Q3 FY19 Q3 Revenue (₹) 1,520 Cr 1,817 Cr 294 Cr 334 Cr 1,814 Cr 2,150 Cr EBITDA (₹) 157 Cr 227 Cr 15 Cr 36 Cr 172 Cr 263 Cr Adjusted PAT2 (₹) 93 Cr 99 Cr (23) Cr 1 Cr 71 Cr 100 Cr Notes: 1. Revenue and EBITDA s
Slide 23: Business – Snapshot (1/2) 9M
I I Business – Snapshot (1/2) GCC INDIA CONSOLIDATED FY18 9M FY19 9M FY18 9M FY19 9M FY18 9M FY19 9M • Total Capacity Beds 867 1,052 3,887 4,038 4,754 5,090 • Operational Beds 752 872 2,759 2,928 3,511 3,800 • ALOS (Days) 2.0 2.0 3.7 3.5 3.1 3.0 • Occupancy 52% 57% 65% 62%* 62% 61% • Outpatient Visi
Slide 24: Business – Snapshot (2/2) 9M
I I Business – Snapshot (2/2) GCC INDIA CONSOLIDATED FY18 9M FY19 9M FY18 9M FY19 9M FY18 9M FY19 9M Revenue (₹) 4,062 Cr 4,802 Cr 874 Cr 960 Cr 4,937 Cr 5,762 Cr EBITDA (₹) 292 Cr 429 Cr 58 Cr 83 Cr 350 Cr 513 Cr Adjusted PAT4 (₹) 55 Cr 138 Cr (61) Cr (13) Cr (6) Cr 125 Cr Notes: 1. Revenue and EBI
Slide 25: Segmental Performance Q3
I I Segmental Performance Q3 India - Unallocated India - Unallocated GCC GCC GCC GCC FY19 Q3 GCC Clinics Hospitals & & Total GCC Clinics Hospitals & & Total Hospitals Pharmacies Hospitals Pharmacies Clinics Eliminations Clinics Eliminations No. of Bus ines s Units (#) 10 105 219 H-11, C-8 NA 353 Ope
Slide 26: Segmental Performance 9M
I I Segmental Performance 9M India - Unallocated India - Unallocated GCC GCC GCC GCC FY19 9M GCC Clinics Hospitals & & Total GCC Clinics Hospitals & & Total Hospitals Pharmacies Hospitals Pharmacies Clinics Eliminations Clinics Eliminations No. of Bus ines s Units (#) 10 105 219 H-11, C-8 NA 353 Ope
Slide 27: Vintage-wise Performance FY19 9M
I I Vintage-wise Performance FY19 9M GCC Hospitals - Revenue (INR Cr) GCC Clinics - Revenue (INR Cr) Consolidated - Revenue (INR Cr)* India Hospitals and Clinics - Revenue (INR Cr) 202 469 92 176 1,716 1,917 1,454 5,292 5,762 1,362 960 785 Established Units Ramp-up units Total Established Units Ramp
Slide 28: Hospitals List
I I Hospitals List Commencement/ Bed Operational Owned Hospitals - GCC Location Acquisition Year Capacity Beds /Leased t===============------- Medca re Hos pi tal Duba i , UAE 2007 64 55 Lea s ed Al Ra ffa Hos pi tal Mus ca t, Oma n 2009 85 74 Lea s ed -----------= Operational Geography ~ Al Ra ffa
Slide 29: Maturity Wise Hospital Performance – GCC FY19 9M
I I Maturity Wise Hospital Performance – GCC FY19 9M Key Performance indicators Revenue Maturity Hospitals Operational Beds (INR in Crs.) EBITDA ARPOBD Occupancy EBITDA % {INR 1n Cr.} 11% 27% 24% ₹(22.7) 3 ₹ 202 236 ₹ ~187,600 Over 3 Years 89% 73% ₹ ~154,600 66% ₹270.1 7 ₹1,716 636 15.7% ₹ 1,917 ₹ ~
Slide 30: Maturity Wise Hospital Performance – India FY19 9M
I I Maturity Wise Hospital Performance – India FY19 9M Key Performance indicators Revenue Maturity Hospitals Operational Beds (INR in Crs.) EBITDA ARPOBD Occupan cy EBITDA % {INR 1n Cr.} 18% 37% ₹ 10.0 2 289 & ₹ ~42,300 51% 5.9 % ₹ 170 798* Over 3 Years 82% 63% ₹ ~23,800 64% ₹92.6 9 ₹781 1841 11.9%
Slide 31: Financial Summary – Profitability Statement (1/2)
I I Financial Summary – Profitability Statement (1/2) Particulars (INR Cr) Revenue from operations Material consumption ---- FY19 Q2 1,837 550 FY18 Q3 1,814 602 FY19 Q3 2,150 655 Gw% 19% Doctors cost 415 381 431 Employee cost (excl. doctors) 385 344 436 Other expenses 272 238 272 EBITDAR 215 250 356
Slide 32: Financial Summary – Profitability Statement (2/2)
I I Financial Summary – Profitability Statement (2/2) Particulars (INR Cr) Revenue from operations Material consumption --- FY18 9m 4,937 1,575 FY19 9m 5,762 1,757 Gw% 17% Doctors cost 1,082 1,246 Employee cost (excl. doctors) 1,023 1,197 Other expenses 668 788 EBITDAR 588 775 32% EBITDAR % 11.9% 13
Slide 33: Financial Summary – Balance Sheet & Ratios
I I Financial Summary – Balance Sheet & Ratios As at Mar 31, As at Dec 31, Particulars (INR Cr) 2018 2018 LIABILITIES Sha rehol ders Equi ty 2,832 3,056 Mi nori ty Interes t 358 412 Debt 2,241 2,642 Other current a nd non-current l i a bi l i ti es 2,054 2,510 Total Liabilities 7,484 8,621 ASSETS Fi
Slide 34: Pipeline Projects
I I Pipeline Projects Expected Completion Owned / Hospitals - GCC Location Type Planned Beds Stage Year Leased/O&M Aster Hospital Sonapur, Dubai, UAE Greenfield 41 Q2 FY 2020 Construction Leased Aster Hospital Sharjah, UAE Greenfield 80 Q4 FY 2020 Construction Leased Greenfield Aster Hospital Muscat
Slide 35: Operational and Financial Overview
I I Aster – Snapshot, Evolution and Footprint ~ Aster – An Integrated Healthcare Provider ~ Operational and Financial Overview Strategy and Leadership 34
Slide 36: ADMHL – Strategy & Outlook (1/2)
I I ADMHL – Strategy & Outlook (1/2) Strengthening of hub and A comprehensive human Scalable systems Strengthening of our medical spoke model in GCC resource strategy utilizing our implementation, tightly tourism network geographical diversity and integrated with catering to future growth operations
Slide 37: ADMHL – Strategy & Outlook (2/2)
I I ADMHL – Strategy & Outlook (2/2) Profitability growth & brand Building of brand, talent Specialized, asset-light Cost Optimization positioning using product- and capability in KSA – a growth in India mix and technology key market in GCC • Focus on margin expansion through • There is significant
Slide 38: India Strategy
I I India Strategy India is geographically well positioned for Focus on In line with medical tourism focus on large format from the GCC hospitals in Tier 1 derisking states, MENA business – cities – Hospitals region and South- in Tier 1 cities The new National Health Protection Scheme target of 25%
Slide 39: Aster Leadership Team
I I Aster Leadership Team Dr. Azad Moopen Dr. Harish Pillai Veneeth Purushotaman Chairman and Managing Director Chief Executive Officer – India Chief Information Officer Alisha Moopen Jobilal M. Vavachan Chief Executive Officer – Chief Executive Officer, Aster Fara Siddiqi GCC Hospitals & Clinics Ph
Slide 40: Aster Board of Directors
I I Aster Board of Directors strategy andleadership Ravi Prasad Daniel James Dr. Azad Moopen Independent Director Snyder Chairman and Managing Director Independent Director Alisha Moopen M. Madhavan Suresh M. Chief Executive Officer – Nambiar Kumar GCC Hospitals & Clinics Independent Director Indepe
Slide 41: Thank You
JHANKYOU 40 www.asterdmhealthcare.com
Aster DM Healthcare — Q3 FY2019 Earnings Presentation on 6ix